Physician profile
Kornelia E Krol
NPI 1538192398
$2,637.98
in general payments reported to CMS, 2019-2025
24 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $496 · 2021: $410 · 2022: $553 · 2023: $254 · 2024: $170 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.29 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $620.66 | 2019-2023 | |
| Avion Pharmaceuticals | $417.39 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $223.65 | 2019-2025 | Paragard T 380a, Summit Doppler, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Exeltis, USA INC. | $162.61 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $144.96 | 2021-2023 | |
| Aspira Women'S Health INC | $117.64 | 2021-2022 | |
| Lupin INC. | $112.02 | 2019-2020 | |
| Millicent US INC | $110.07 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Dysis Medical, INC. | $86.31 | 2019 | |
| Myriad Women'S Health, INC. | $82.39 | 2023 | Myrisk |
| Astellas Pharma US INC | $70.64 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $69.66 | 2022 | |
| Amgen INC. | $67.45 | 2019 | |
| Medtronic, INC. | $67.43 | 2021-2025 | Truclear |
| Pfizer INC. | $62.24 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $36.84 | 2021 | |
| Hologic Sales and Service, LLC | $33.79 | 2019-2020 | |
| Mission Pharmacal Company | $28.01 | 2019 | |
| Organon LLC | $27.10 | 2023 | Nexplanon |
| Allergan, INC. | $26.75 | 2019 | |
| Meditrina | $26.56 | 2022 | |
| Scynexis, INC. | $15.05 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.41 | 2023 | Seglentis |
| Channel Medsystems, INC. | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kornelia Krol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.